In vitro investigation of wavelength-dependent tissue ablation: Laser prostatectomy between 532 nm and 2.01 μm

Lasers in Surgery and Medicine

Volumn 42, Issue 3, 2010, Pages 237-244

  Kang, Hyun Wook ^a   Kim, Jihoon ^b   Peng, Yihlih Steven ^a  

^a American Medical Systems   (United States)

^b Northwestern University   (United States)

Author keywords

Ablation efficiency; Benign prostate hyperplasia; Histology; Laser prostatectomy

Indexed keywords

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; INTERMETHOD COMPARISON; KIDNEY PARENCHYMA; LASER PROSTATECTOMY; LIGHT SCATTERING; NONHUMAN; OPTICAL ROTATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SWINE; THERMAL INJURY; TISSUE NECROSIS;

ANIMALS; BIOPSY, NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LASER THERAPY; LASERS, EXCIMER; MALE; MODELS, ANIMAL; PROBABILITY; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; SAMPLING STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SWINE;

EID: 77950527155     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20895     Document Type: Article

References (15)

1. Kuntzmann RS, Malek RS, Barrett DM. High-power potassium titanyl phosphate laser vaporization prostatectomy. Mayo Clinic Proc 1998;73:798-801.
2. Jacobsen SJ, Girman CJ, Guess HA, et al. New diagnostic and treatment guidelines for benign prostatic hyperplasia: Potential impact in the United States. Arch Intern Med 1995;155:477-481.
3. Hoffman RM, MacDonald R, Slaton JW, et al. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: A systematic review. J Urol 2003;169:210-215.
4. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassiumtitanyl- phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005;174:1344-1348.
5. Te AE. Current state of the art photoselective vaporization prostatectomy: Laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2007;10:S2-S5.
6. Rosette JDL, Collins E, Bachmann A, et al. Historical aspects of laser therapy for benign prostatic hyperplasia. Eur Urol Suppl 2008;7:363-369.
7. Malek RS, Nahen K. Photoselective vaporization of the prostate: KTP laser therapy of obstructive benign prostatic hyperplasia. AUA Update Series 2004;23:153-160.
8. Naspro R, Bachmann A, Gilling P, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate. Eur Urol 2009;55:1345-1357.
9. Jacques SL. Laser-tissue interactions: Photochemical, photothermal, and photomechanical. Lasers Gen Surg 1992;72:531-558.
10. Seitz M, Reich O, Gratzke C, et al. High-power diode laser at 980nm for the treatment of benign prostatic hyperplasia: Ex vivo investigations on porcine kidneys and human prostates. Lasers Med Sci 2009;24:172-178.
11. 2 laser. SPIE Proc 1998;3565:110-115.
12. Kang HW, Jebens D, Malek RS, et al. Laser vaporization of bovine prostate: A quantitative comparison of potassiumtitanyl-phosphate and lithium triborate lasers. J Urol 2008;180:2675-2680.
13. Chan KF, Vassar GJ, Pfefer TJ, et al. Holmium:YAG laser lithotripsy: A dominant photothermal ablative mechanism with chemical decomposition of urinary calculi. Lasers Surg Med 1999;25:22-37.
14. Vogel A, Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chem Rev 2003;103:577-644.
15. Niemz MH. Laser-tissue interactions. Berlin: Springer-Verlag; 1996.